It's no wonder Macquarie sold down in the Ipo when one of Nuixs main competitors Exterro had just gotten much bigger after acquiring AccessData. It's not like Macquarie to sell out for no reason. They still hold 30% but I believe they can sell them in a few months.
https://www.datamation.com/applications/trends-in-information-governance-ediscovery-and-big-data/eDiscovery is a perennial IG development driver, with software tools existing to aid in collection and analysis throughout the EDRM workflow. In addition, eDiscovery software makers often engineer their products to work with related processes including records management and compliance. IG-related eDiscovery tools are not relegated to eDiscovery software makers: file analysis products often provide eDiscovery tools as well.
Of the pure eDiscovery vendors,Exterrois a full-service eDiscovery provider whose platform includes IG tools like E-Discovery Data Mapping.AccessDataandNuix Luminatealso provide robust IG tools.
https://www.exterro.com/blog/exterro-acquires-digital-forensics-firm-accessdata
Exterro has acquired leading digital forensics provider AccessData.
The acquisition furthers Exterro’s vision of empowering customers to proactively and defensibly manage their legal governance, risk and compliance (GRC) obligations while maintaining and ensuring the highest levels of data integrity. By combining forces with AccessData, Exterro can now provide companies, government agencies, law enforcement, law firms and legal service providers with the only solution available to address all Legal GRC and digital investigation needs in one integrated platform.
- Forums
- ASX - By Stock
- NXL
- Ann: Response to market commentary
Ann: Response to market commentary, page-125
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.29 |
Change
-0.215(3.31%) |
Mkt cap ! $2.027B |
Open | High | Low | Value | Volume |
$6.37 | $6.37 | $6.11 | $11.70M | 1.887M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 7180 | $6.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.29 | 1291 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 3561 | 6.270 |
14 | 11259 | 6.260 |
11 | 8864 | 6.250 |
8 | 4621 | 6.240 |
10 | 3828 | 6.230 |
Price($) | Vol. | No. |
---|---|---|
6.280 | 2361 | 8 |
6.290 | 3647 | 15 |
6.300 | 5174 | 11 |
6.310 | 5581 | 7 |
6.320 | 6291 | 7 |
Last trade - 14.42pm 15/11/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online